Table 3.
Separate logistic regression analysis models for calprotectin and CRP to predict PD synovitis.
| Model 1 | OR | 95% CI | p |
| Age | 1.007 | 0.955 – 1.062 | 0.794 |
| Gender | 1.614 | 0.389 – 6.692 | 0.510 |
| Disease duration | 1.016 | 0.953 – 1.084 | 0.619 |
| SJC | 2.020 | 0.932 – 4.379 | 0.075 |
| ACPA positivity | 1.530 | 0.499 – 4.697 | 0.457 |
| Calprotectin | 1.014 | 1.002 – 1.027 | 0.024 |
| Model 2 | OR | 95% CI | p |
| Age | 1.006 | 0.955 – 1.060 | 0.818 |
| Gender | 1.327 | 0.345 – 5.101 | 0.681 |
| Disease duration | 1.018 | 0.958 – 1.083 | 0.562 |
| SJC | 2.347 | 1.033 – 5.332 | 0.042 |
| ACPA positivity | 1.119 | 0.385 – 3.251 | 0.837 |
| CRP | 1.009 | 0.974 – 1.045 | 0.630 |